As part of ACC's ongoing involvement in the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) process, the College distributes RUC physician work surveys ...

Access ACC guidelines and clinical policy documents as well as related resources ...

In a world saturated with headlines highlighting breakthroughs in artificial intelligence and virtual reality, robotics may seem somewhat conventional. But, in fact, robotic-assisted solutions for ...

These trials highlight the potential of RDN as a viable therapeutic option for patients with treatment-resistant hypertension, he adds, and, notably, demonstrate efficacy in reducing BP independently ...

Quick Takes Colchicine is an anti-inflammatory drug approved by the Food and Drug Administration for reduction of cardiovascular risk. Low-dose colchicine has shown significant reduction in ...

Until recently, the story of the tricuspid valve was that patients with significant TR suffered for a long time but were undiagnosed until their disease was severe. Then there weren't really any ...

Are you interested in finding a Cardio-Oncology training program or fellowship? Browse our current list to see what's available.

The increasing frequency and intensity of extreme weather events and wildfires, driven by climate change, pose a growing threat to cardiovascular health. This was starkly illustrated in January 2025 ...

Introduction Mitral regurgitation (MR) is the most frequently encountered valvular lesion in clinical practice and is associated with significant morbidity and mortality. Previously, surgical mitral ...

The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, along with the aging population and the ongoing rise in risk factors such as hypertension, ...

Between 2% to 3% of all patients and 5% to 6% of all women who present with what looks like an acute coronary syndrome (ACS) are actually suffering from a peculiar and reversible acute cardiac ...

In the rapidly evolving health care landscape, acute coronary syndromes (ACS) continue to be a leading cause of morbidity and mortality worldwide. Each year, an estimated 1.2 million individuals in ...